MétaCan
Menu
← Back to cohort

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

2006· article· en· W2535579634 on OpenAlexaff
Laurie H. Sehn, Mukesh Chhanabhai, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Judy Sutherland, Randy D. Gascoyne, Joseph M. Connors

Bibliographic record

VenueBlood · 2006
Typearticle
Languageen
FieldMedicine
TopicLymphoma Diagnosis and Treatment
Canadian institutionsUniversity of British ColumbiaBC Cancer Agency
Fundersnot available
KeywordsMedicineInternational Prognostic IndexDiffuse large B-cell lymphomaInternal medicineRituximabCHOPPopulationStage (stratigraphy)LymphomaGastroenterologyPerformance statusOncologyCancer

Abstract

fetched live from OpenAlex

Abstract Background: DLBCL is a heterogeneous entity with patients exhibiting a wide range of clinical outcomes. A reliable prediction tool is vital for optimizing patient care. We have previously demonstrated that a revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI following treatment with rituximab and CHOP (CHOP-R). (Sehn, ASH 2005). Further exploration of clinical prognostic factors in an expanded cohort of patients yields a simplified prediction model based on stage and LDH alone. Methods: We performed a retrospective analysis to assess the predictive value of recognized clinical prognostic factors in an unselected population of patients with DLBCL treated with CHOP-R. Patients were identified using the Lymphoid Cancer Database of the British Columbia (BC) Cancer Agency and included all patients >16 y of age who were newly diagnosed with DLBCL prior to Jan 15, 2006, treated in BC with a CHOP-R protocol. Patients were excluded if they were HIV positive, had evidence of an active second malignancy or an underlying indolent NHL. Results: 523 patients were identified with the following characteristics: median age 61 y (16–93); male, 60%; stage III/IV, 55%; elevated LDH, 53%; performance status (PS) ≥2, 41%; ≥2 extranodal sites, 29%. Patients with advanced stage lymphoma (stage III/IV, B symptoms or bulky disease) or patients who were not candidates for radiation therapy were treated with 6–8 cycles of CHOP-R (91%) while those with limited stage were treated with CHOP-Rx3 and involved field radiation therapy (9%). Median follow-up for living patients is 24 months. On univariate analysis, stage, PS and LDH remain predictive for both PFS and OS. Number of extranodal sites is a borderline predictor of PFS (p=0.05) and no longer predictive of OS (p=0.276). Although age no longer predicts for PFS (p=0.17), it remains predictive of OS (p=0.001) since elderly patients are less likely to be treated successfully with secondary therapy and more likely to die from unrelated causes. On multivariate analysis, only stage (p<0.001) and LDH (p<0.001) remain significant predictors of PFS with similar predictive capacity (relative risk 2.7 and 3.0 respectively). A prediction model based on these two factors alone can predict outcome (see Table) as effectively as the full 5-factor IPI. Conclusions: A prediction model based on stage of disease and serum LDH level at presentation provides an accurate estimate of outcome following primary therapy with CHOP-R for patients with DLBCL.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.009

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.007
GPT teacher head0.198
Teacher spread0.191 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2006
Admission routes1
Has abstractyes

Explore more

Same venueBlood→Same topicLymphoma Diagnosis and Treatment→French-language works237,207→